ArticleMultiple sclerosis journal - experimental, translational and clinical

Glatiramer acetate as a clinically and cost-effective treatment of relapsing multiple sclerosis over 10 years of use within the National Health Service: Final results from the UK Risk Sharing Scheme.

G Giovannoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.